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Abstract
Background: Mammary stem cells are maintained within specific microenvironments and recruited throughout lifetime to
reconstitute de novo the mammary gland. Mammary stem cells have been isolated through the identification of specific cell
surface markers and in vivo transplantation into cleared mammary fat pads. Accumulating evidence showed that during the
reformation of mammary stem cell niches by dispersed epithelial cells in the context of the intact epithelium-free mammary
stroma, non-mammary epithelial cells may be sequestered and reprogrammed to perform mammary epithelial cell
functions and to adopt mammary epithelial characteristics during reconstruction of mammary epithelium in regenerating
mammary tissue in vivo.
Methodology/Principal Findings: To examine whether other types of progenitor cells are able to contribute to mammary
branching morphogenesis, we examined the potential of murine embryonic stem (mES) cells, undergoing hematopoietic
differentiation, to support mammary reconstitution in vivo. We observed that cells from day 14 embryoid bodies (EBs) under
hematopoietic differentiation condition, but not supernatants derived from these cells, when transplanted into denuded
mammary fat pads, were able to contribute to both the luminal and myoepithelial lineages in branching ductal structures
resembling the ductal-alveolar architecture of the mammary tree. No teratomas were observed when these cells were
transplanted in vivo.
Conclusions/Significance: Our data provide evidence for the dominance of the tissue-specific mammary stem cell niche
and its role in directing mES cells, undergoing hematopoietic differentiation, to reprogram into mammary epithelial cells
and to promote mammary epithelial morphogenesis. These studies should also provide insights into regeneration of
damaged mammary gland and the role of the mammary microenvironment in reprogramming cell fate.
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Introduction
Mammary gland development occurs mostly postnatally and is
dependent on a complex interplay of systemic hormones and
local growth factors [1,2,3]. The mammary gland is composed of
a network of branching ducts that terminate in sac-like lobules
embedded in stromal tissue. There are two primary epithelial cell
lineages, the myoepithelial and the luminal cells (comprised of
ductal and alveolar subtypes), which are presumed to arise from a
common progenitor cell. Generation of a functional mammary
gland from a single mammary stem cell has been reported by two
groups [4,5]. A discrete population of mouse mammary cells with
cell-surface markers Lin
2CD29hiCD24
+ was found to be
enriched for transplantable mammary stem cells [4]. It was also
reported that a single cell, CD45
2Ter119
2CD31
2Sca1
low
CD24
medCD49f
high, marked with a LacZ transgene, was able to
reconstitute a complete mammary gland in vivo. The transplanted
cells contributed to both the luminal and myoepithelial lineages
and generated functional lobulo-alveolar units during pregnancy
[4,5].
The cleared fat-pad transplantation system provides a useful in
vivo system for studying mammary epithelial morphogenesis [6].
This method is based on the fact that the mouse mammary gland
is not fully developed at 3 weeks of age, making it possible to excise
the rudimentary mouse mammary epithelium from the fat pad,
resulting in a cleared fat pad devoid of any epithelium. Subsequent
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yields an anatomically normal functional mammary gland.
The mammary microenvironment plays important function in
the regeneration of mammary gland. Mammary stem cells are
maintained within specific microenvironments (niches) in the
mammary gland and these mammary stem cell niches can be
reconstituted de novo by mammary epithelial cells as shown in
several studies [7,8,9,10,11,12,13]. Transplanted epithelial cells
from the glands can induce mammary regeneration by providing a
niche with local signaling cells and extracellular matrix that sustain
stem cells [14]. Additionally, parity-identified mammary epithelial
cells (PI-MEC), originating from differentiating cells during
pregnancy, were shown to possess pluripotency and self-renewal
upon transplantation and contributed progeny directly to the
formation of secretory acini upon subsequent pregnancies [11,13].
Interestingly, a recent study [15] showed that testicular cells can
interact with the mammary epithelial cells within the mammary
stroma, proliferate and contribute to epithelial cell progeny,
resulting in mammary outgrowth. These testicular cells, when
mixed with mammary epithelial cells and when transplanted into
denuded mammary fat pads, were able to adopt a mammary
epithelial cell phenotype, indicating that the mammary niche can
redirect spermatogenic cell fate into mammary epithelial cell fate
in vivo. Further, murine fetal and adult neural stem cells (NSCs)
when mixed with equal numbers of mammary epithelial cells
(MECs) and inoculated into epithelium-divested mammary fat
pads of prepubertal female mice, the NSCs contributed to
mammary epithelial specific progeny and mammary outgrowths
(16). Thus, non-mammary tissues could be altered from their
initial cell fate lineage to adopt mammary epithelial characteristics
upon interaction with mammary epithelial cells during recon-
struction of mammary epithelium in regenerating mammary tissue
in vivo (17). However, it is unknown whether other sources of stem
cells can generate epithelial progenitors that can reconstitute
mammary tissues without the contribution of MECs. Here, in this
study, we examined whether murine embryonic stem (mES) cells,
undergoing hematopoietic differentiation, can support the recon-
stitution of mammary outgrowth when transplanted into epithe-
lium-divested mammary fat pads.
Embryonic stem (ES) cells are pluripotent cells derived from the
inner cell mass [16,17]. These cells are capable of undergoing an
unlimited number of symmetrical divisions without differentiation.
In addition, these cells can give rise to differentiated cell types of all
three primary germ layers of the embryo [18]. To address whether
mES cells can contribute to mammary epithelial morphogenesis,
we established three-dimensional (3-D) cultures of mES, using
E14, E14-GFP and Rosa26.6 ES cell lines, for differentiation into
MECs. E14-GFP is a mouse ES cell line with green fluorescence
protein (GFP) and the Rosa26.6 cells contain a LacZ, which was
used for cell lineage tracing. In addition, we analyzed the potential
of mES cells undergoing hematopoietic stem cell differentiation for
their ability to induce mammary epithelial morphogenesis in vivo
in mice and established the conditions for such reprogramming of
cell fate in the mammary microenvironment.
Results
The Potential of Murine ES Cells to Differentiate Into
Mammary Epithelial Cells
To assess the multilineage differentiation potential of mES cells
to generate in vitro complex functional structures reminiscent of the
mammary tree, we employed the 3-D cultivation system which
provides the physiological signal necessary for mammary mor-
phogenesis in vitro and enables mammary cells to recapitulate the
spatial orientation and architecture of the mammary tree in vivo
[11,13]. The differentiation potential of mES cells was assessed by
determining the ability of mES cells to develop functional ductal-
alveolar-like structures using Matrigel matrix. Acini structures
were generated in vitro by mES cells, the E14-GFP and Rosa 26.6
ES cells, when cultured in epithelial media under 3D-culture
conditions (Figure 1A). Nuclear staining and confocal microscopy
showed elongated hollow tubular structures (Figure 1A, panels ii-
iii). Next, these cells were tested for expression of the mammary
gland cell-lineage specific markers CK5, CK14, WAP and b-
casein. These cells were positive for CK5 and CK14, but negative
for b-casein and for the specific mammary whey acidic protein
(WAP) (Figure 1B). When these 3D mammary epithelial cells were
examined for their potential to support mammary branching
morphogenesis in vivo, these cells failed to differentiate in vivo along
all three mammary gland cell lineages and were unable to
structurally and functionally recapitulate the architecture of the
mammary gland.
Hematopoietic differentiation of murine ES cells and their
transplantation into denuded mammary fat pads
Next, we examined the potential of embryoid bodies (EBs)
derived from GFP-E14 mES cells to reconstitute mammary
epithelial morphogenesis. First, we used EBs formed in medium
without specific growth factors to allow random differentiation of
ES cells. Transplantation of these EBs failed to induce mammary
epithelial branching morphogenesis. Next, we employed EBs
formed under hematopoietic differentiation conditions following
established protocols (StemCell Technologies, Vancouver, Ca-
nada) involving a two-step EB method. First, spherical cell EB
aggregates were generated that contain ectodermal, mesodermal
and endodermal derivatives (Primary Differentiation). EB aggre-
gates were then selected for hematopoietic precursors and
expanded with growth factors consisting of EPO, IL-3 and IL-6
(Secondary Hematopoietic Differentiation). Cells were processed
for the Wright-Giemsa staining; RT-PCR and Western blot
experiments at different times of EB culture differentiation as
indicated.
Expression of hematopoietic specific markers, such as Bata-H1,
Tie-2, Flk-1, Sca-1 and PECAM-1 were analyzed in EBs. As
expected (Figure 2), hematopoietic-differentiated EBs derived from
GFP-E14 mES cells at day 8 and day 14 expressed Bata- H1/
Sca1
+/Flk1
+/PECAM1
+. These EB-derived from GFP-E14 mES
cells were then transplanted into denuded mammary fat pads.
Substantial engraftment of the fat pad by EBs at day 14 was
evident (Figures 3–4).
Histological sectioning of the mammary glands revealed normal
ductal structures composed of both luminal and myoepithelial
cells, as indicated by carmine staining and immunostaining with
specific luminal marker cytokeratin 18 (CK18) or the myoepithe-
lial marker cytokeratin 14 (CK14) (Figure 3B, 3C, 3D). We found
that while EBs at day 7 were unable to support mammary
outgrowths, the EBs at day 14 undergoing hematopoietic
differentiation, contributed to the reconstitution of ,26% of the
mammary fat pads. The contribution of mammary morphogenesis
by day 14 EBs derived from GFP-E14 mES cells, resulted in
functional reconstitution of the mammary tissue as revealed by
Carmine analysis, GFP expression, and expression of cytokeratin
14 and 18 at 8 weeks post transplantation (Figure 3B, 3C).
Reconstitution was observed in 10 denuded mice out of 38 mice
transplanted with GFP-E14 mES cells, while no reconstitution was
observed in denuded mice transplanted with either GFP-E14-EBs
at day 7 or at day 0 (Figure 4A, 4B). Importantly, we did not
observe any reconstitution of denuded mammary fat pads injected
Mammary Gland Reconstitution
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cleared (Figure 4).
Examination of the mammary fat pads for GFP expression (for
EBs derived from E14-GFP) or with LacZ staining (for EBs
derived from Rosa26.6 ES cells) 8 weeks after injection clearly
demonstrated sites of engraftment and expansion of these EB cells
in ,25% of the total inoculated fat pads (Figure 5A). In addition,
in order to estimate the efficiency of reconstitution, we performed
a dose response by increasing the number of transplanted day-14
EB-derived cells from 10
5 to 10
6,5 610
6 and 10
7. Transplantation
of these EB-derived cells resulted in an enhanced number of
reconstituted mammary morphogenesis (Figure 5A, 5B). Of note,
we did not observe any cases of teratoma formation when cells
from day 7 or 14 EBs were transplanted into mammary fat pads (a
Figure 2. Time course of hematopoietic differentiation of mES-E14/GFP. Differentiated hematopoietic EBs at days 8 and 14 were analyzed
by RT-PCR analysis. This is a representative experiment out of 5.
doi:10.1371/journal.pone.0009707.g002
Figure 1. mES cells were able to clonally reproduce acini in vitro. (A) Confocal microscopy of mES E14-GFP cells (Panels A(i) and A(ii) and Rosa
26.6 ES cells Panel A(iii) showing acini structures. The mES cells were grown in epithelial media under 3D Matrigel matrix conditions. Cells were grown
for 10 days and stained with control IgG (Panel i) or with CK14 antibody (Panel ii), or with cytokeratin CK 18 (Panel iii). In addition, nuclear staining
(DAPI) was performed, and is shown at 60X magnification (scale bar, 20 mm). This is a representative experiment out of four experiments. (B) RT-PCR
analysis of 3-D mammary epithelial cell cultures derived from 3D-E14-ES cells (lane 1) 3D-Rosa 26.6 mES cells (lane2), control Rosa ES cells and E14-ES
cells, respectively (lanes 3 and 4). Specific primers for murine b-casein, WAP, CK 5, CK 14 and GAPDH were used in this analysis. This is a representative
experiment out of 3.
doi:10.1371/journal.pone.0009707.g001
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performed), while mES cells without differentiation formed
teratoma in vivo (data not shown).
Supernatants derived from EBs failed to support
mammary reconstitution
To further assess the importance of the contribution of cells
from murine hematopoietic EBs to the reconstitution of mammary
branching morphogenesis, denuded mammary fat pads were
injected with supernatants derived from EBs at days 7 and 14.
While the reconstitution of mammary epithelial morphogenesis
was observed with day-14 EB cells (as revealed by carmine
staining, GFP expression and expression of cytokeratins 14 and 18
at 8 weeks post transplantation), supernatants generated with day-
7 and day-14 EBs injected into denuded mammary fat pads
(n=20) failed to induce the reconstitution of mammary epithelial
morphogenesis (data not shown). These results indicate that the
presence of cells from hematopoietic differentiated murine EBs
contributing progenitor cells for mammary outgrowths are needed
in the denuded mammary fat pads in order to interact with the
stroma microenvironment within the mammary fat pads and to
contribute to the reconstitution de novo mammary outgrowths.
Demonstration of Y chromosome-specific sequences in
mammary glands
PCR analysis of the DNA isolated from the reconstituted
mammary outgrowths demonstrated the presence of sequences
specific to the Y chromosome, verifying the presence of the donor
murine ES cell DNA (Figure 5C). Positive cells were detected for
the Y chromosome, suggesting that hematopoietic EBs derived
Figure 4. Reconstitution of mammary epithelium by mES cells. (A) Whole-mount staining of transplanted mammary glands. The 4
th
mammary fat pad of 3 weeks old female mice were denuded and transplanted with either E14 mES cells, or EBs at day 7 or EBs at day 14, (ES cells
were in-vitro differentiated in Methylcellulose into hematopoietic EBs at day 14 or at day 7), as indicated. Eight weeks after transplantation, whole-
mount staining of the mammary fat pads were performed with carmine staining (magnification 2X, scale bar: 10 mm). (B) Virgin recipients harvested
8 weeks after transplantation with hematopoietic EB-derived E14-GFP ES cells at days 0, 7 and 14, as indicated. As a control, the mammary fat pad was
denuded and injected with PBS at the same time and under the same conditions as the other samples. After 8 weeks of transplantation, the
mammary fat pads were analyzed with carmine staining, GFP staining, CK 14, CK 18 and by whole mount analysis of epithelial outgrowths arising
from transplantation. Controls were mammary fat pads from denuded mice without transplantation. *Statistical significance p,0.005.
doi:10.1371/journal.pone.0009707.g004
Figure 3. Hematopoietic EB-derived E14 (GFP) mES cells at day 14 can reconstitute mammary fat pads. (A) Sections of WT mammary fat
pads derived from 2 control mice stained with anti-GFP antibody. This served as negative control for GFP staining (20X magnification; scale bar,
100 mm). (B-C) Sections of GFP+ outgrowths derived from reconstituted mammary fat pads from mice stained with GFP, carmine, CK 14 and CK 18 as
indicated. 206magnification for GFP and Carmine staining. B: (scale bar, 100 mm), 40X magnification for CK18 and CK14 staining (scale bar, 50 mm) C:
20X magnification (scale bar, 100 mm). These are representative analyses of immunostaining of transplanted mammary fat pads, out of 56
transplanted mammary fat pads. (D) Reconstituted mouse mammary epithelial cells stained for either control antibodies or for both CK 18 (red) and
CK 14 (green). 49,6-diamidino-2-phenylindole (DAPI) (blue) was used to stain the nuclei. 1:300 diluted polyclonal antibody of CK 14 (Covance,
Catalogue number PRB-155p) and 1:300 diluted monoclonal antibody of CK 18 were used for immunostaining. Secondary antibodies were added and
sections were imaged using a confocal microscope (60X magnification; scale bar, 20 mm).
doi:10.1371/journal.pone.0009707.g003
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Immunostaining and whole-mount analysis of epithelial outgrowths induced bytransplantation of day14 EBs. (B) The mammary fat pads were
analyzed with carmine staining, GFP staining, CK 14, CK 18 and by whole mount analysis of epithelial outgrowths arising from transplantation. (C)
FISH with mouse X and Y chromosome probes on reconstituted mammary gland. Mouse X and Y chromosome FISH analysis were used on paraffin-
embedded sections of reconstituted mammary glands with mEBs derived from E14-GFP mES cells at day 14. The X chromosome was labeled in red
Mammary Gland Reconstitution
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resulting in mammary outgrowths.
Discussion
While all previous reports had demonstrated the reconstitution
of mammary morphogenesis using mammary epithelial progenitor
cells, this study provides the first description, to our knowledge, of
the reconstitution of the mammary morphogenesis using cells that
were not derived from primary mammary tissues. Here we showed
that mammary morphogenesis can be induced and promoted by
transplantation of murine ES cells undergoing hematopoietic
differentiation. The transplanted EB-derived cells were able to
contribute to branching duct-like structures that recapitulate the
ductal-alveolar-like architecture of the mammary tree, providing
support to both the luminal and myoepithelial lineages. We did
not observe teratoma formation when these cells were transplanted
in vivo. These results strongly suggest the importance of the
mammary gland microenvironment for the generation of breast
epithelial cells, derived from murine ES cells undergoing
hematopoietic differentiation.
The interaction of epithelial cells with the stromal cells in the
mammary gland is critical for mammary gland development and
the differentiation into luminal and myoepithelial cell lineages.
The epithelial tissue-specific stem cells are dispersed throughout
the mammary gland and are maintained in the surrounding
microenvironment. A parity-induced mammary epithelial cell
population (PI-MEC) that possesses the properties of pluripotency
and self-renewal upon transplantation was shown to reconstitute
mammary outgrowth and morphogenesis [15]. Recently, epithelial
cells derived from testicular cells, when supplied with mammary
epithelial cells [15], were shown to alter their cell fate upon
interaction with the mammary gland microenvironment during
pregnancy, lactation and involution. These testicular cells were
able to interact with the mammary epithelial cells within the
stroma, proliferate and contribute epithelial cell progeny to the
resulting mammary outgrowth. Here, we extended these observa-
tions and showed that murine hematopoietic cells derived
from mES cells were also able to reconstitute of mammary
morphogenesis.
These studies support the notion that the mammary tissue
microenvironment has a critical role in reprogramming the
intrinsic nature of cells from an alternative adult tissue and can
redirect stem cell fate when transplanted into mammary fat pad.
Our experimental data showed that mES undergoing hematopoi-
etic differentiation can directly reprogram to epithelial progeny
and de novo regeneration of stem cell niches in the mammary
glands based on the following data:
1) In all control experiments where denuded fat pads had sham
injection of PBS and no exogenous cells, we never observed
any reconstitution of mammary gland.
2) No reconstitution was observed when murine cells from
embryoid bodies undergoing random differentiation were
transplanted. Reconstitution was observed only when murine
cells were used from EB bodies generated under conditions
that promote hematopoietic differentiation.
3) Reconstitution from transplanted murine cells was further
supported by the use of GFP-tagged ES cell line. GFP+ cells
were observed in branching mammary cells that stained also
for carmine and other specific marker for luminal (CK18) and
myoepithelial (CK14) cytokeratin.
Taken together, the study provides clear evidence for the ability
of differentiated murine ES cells enriched for hematopoietic
progenitor cells to regenerate mammary morphogenesis in vivo.
The study provides clear evidence for the critical role of the
mammary microenvironment in determining progenitor cell fate
and mammary cell function. The assay we described is useful for
studying ‘‘mammary morphogenesis’’ with potential application as
a possible model system for drug discovery.
Materials and Methods
E14 differentiation to epithelial cells in 3D culture
Growth Factor Reduced Matrigel was purchased from BD
Biosciences (354230). Fifty ml of growth factor reduced matrix gel
was added to each well chamber. The chambers were placed in a
cell culture incubator to allow the basement membrane to solidify
for at least 20 minutes. While the Matrigel was solidifying, ES cells
were trypsinized and single cells were seeded on Growth Factor
Reduced Matrigel. The cells were grown in mammary epithelial
cell media purchased from Clonetics (CC-4136), containing 2%
FBS and 2% Matrigel. Every two to three days, the media were
replaced with fresh media. The cells formed clusters by day 4–6 of
the 3-D cultures and subsequently started forming hollow lumen
[19]. Cells were then analyzed for specific mammary epithelial cell
markers by confocal microscopy and RT-PCR methods.
Derivation of embryoid bodies from ES cells
The Rosa26.6 ES cell line was obtained from Dr. Stuart Orkin
(Children’s Hospital, Harvard Medical School); The E14 and
GFP-E14 cell lines were obtained from Dr. Bing Lim (Beth Israel
Deaconess Medical Center, Boston). Culture and maintenance of
ES cells in an undifferentiated state were performed as described
previously [20]. Briefly, ES cells were maintained on a mouse
Primary Embryonic Fibroblast (PEF) feeder cell line in ES medium
containing Dulbecco’s modified Eagle’s medium (DMEM) with
high glucose, 10 ng/ml murine leukemia inhibitory factor (mLIF;
Chemicon International, Temecula, CA), 15% fetal calf serum
(FCS; Hyclone, Logan, UT), 1 mM sodium pyruvate, 2 mM
glutamine, 0.1 mM nonessential amino acids, 100 mM mono-
thioglycerol (MTG; Sigma), 50 U/ml penicillin, and 10 mg/ml
streptomycin. The ES cell lines were regularly analyzed by using
an ES cell characterization kit (Chemicon), for determination of
alkaline phosphatase activity and detection of surface markers and
transcription factors that are expressed by undifferentiated ES
cells, such as Oct-4, Rex-1, SSEA-1 and FoxD3 (Genesis).
In vitro hematopoietic differentiation of ES cells was performed
as described, essentially according to the protocol of StemCell
Technologies. The embryoid body (EB) method involves two steps:
first, spherical cell aggregates (termed embryoid bodies=EBs) are
generated that contain ectodermal, mesodermal and endodermal
derivatives (=Primary Differentiation); second, these aggregates
are selected for hematopoietic precursors and expanded with
growth factors such as EPO, IL-3 and IL-6 (=Secondary
Hematopoietic Differentiation). Briefly, EBs were generated in
1% methylcellulose cultures (1610
4 ES cells per 35 mm Petri dish).
and the Y chromosome (detecting mES cells derived EBs) was labeled in green (y). The nuclei were stained with DAPI. a. Positive mammary epithelial
cell for both x and y probes (6100 magnification); b. Positive mammary epithelial cells for both x and y probes are shown, as detected in the duct
sections of the reconstituted mammary fat pads with EBs at day 14 (660 magnification).
doi:10.1371/journal.pone.0009707.g005
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cultured in ES differentiation medium containing Iscove’s
modified Dulbecco’s medium (IMDM), 15% FBS, 2 mM L-
glutamine, 150 mM MTG, and 40 ng/ml mSCF. After 8 days of
differentiation, the EBs were collected and washed. 1610
4 of
single cells were seeded on 1% methylcellulose from the secondary
hematopoietic differentiation medium. 15% FBS, 2 mM L-
glutamate, 150 mM MTG, 20% BIT (10% BSA, 10 mg/ml insulin,
200 mg/ml transferrin), 150 ng/ml mSCF, 30 mg/ml IL-3, 30 mg/
ml IL-6 and 3 U/ml Epo were added to the culture to promote
hematopoietic differentiation. Cells were processed for Wright-
Giemsa staining, RT-PCR and Western blot analyses at different
times of EB culture differentiation, as indicated.
To determine the characteristics of various types of hemato-
poietic progenitors present during ES cell differentiation, EBs from
ES cell lines were collected from the cultures at days 8 and 14
(from the day of replating) to obtain the hematopoietic
progenitors. Following cytospin preparation of these cells, they
were stained with Wright-Giemsa and examined under a light
microscope. Undifferentiated ES cells have a large nucleus,
minimal cytoplasm, and one or more prominent dark nucleoli.
Hematopoietic progenitors found in EB-day 14 cultures were
identified by the morphology of erythroids, megakaryocytes,
monocytes/macrophages, granulocytes and mast cells, as analyzed
by brightfield microscopy.
Mammary Fat Pad Transplantation and Analysis
Murine cells were resuspended in PBS and into the inguinal
mammary glands of 3-week-old female BALB/c mice that had
been cleared of endogenous epithelium. All mice were housed in
AAALAC-accredited facilities in accordance with the NIH Guide
for the Care and Use of Laboratory Animals. The BIDMC and
Harvard Medical School Committees approved all experimental
procedures. Recipient glands were removed for evaluation after 8
weeks unless otherwise stated. Whole mounts of wild-type
mammary outgrowths were stained with hematoxylin. LacZ
+
outgrowths were detected by X-Gal staining. GFP
+ outgrowths
were detected by GFP staining. An outgrowth was defined as an
epithelial structure comprised of ducts arising from a central point,
with lobules and/or terminal end buds.
Immunostaining
Paraffin-embedded sections were deparaffinized and dehydrat-
ed, washed in PBS, and subjected to antigen retrieval using
treatment with 150 mM glycine, microwaved for 15 minutes,
before blocking. Primary antibody staining was performed
overnight at 4uC, while secondary antibody staining was
performed for 30 minutes and DAPI staining for 5 minutes at
room temperature. Antibodies for GFP, cytokeratin 14 (Covance)
and cytokeratin 18 (Progen Biotechnik) were used for immuno-
histochemistry. Fluorochrome-conjugated secondary antibodies
included anti-rabbit and anti-mouse Ig-Alexa594 and anti-rabbit
Ig-Alexa488 (Molecular Probes). Matrigel cultures were prepared
and immunostained as described [21]. Sections were imaged using
a confocal microscope (Zeiss LAM 510Meta). For human and
murine adult hematopoietic stem cell transplantation, the paraffin-
embedded sections were immunostained with human (cytokeratin
Pan) (ABR Catalog #MA1-26268) and murine (cytokeratin 18
and 14) (Zymed Laboratories).
Whole Mounts and Immunohistochemistry
For murine whole-mount analysis, fresh mammary tissue was
flattened and fixed in Carnoy’s solution (ethanol, glacial acetic
acid, and chloroform) and subsequently stained with carmine alum
(carmine, AlKSO4).
Differentiation Culture Conditions, Cell Fixation, Staining,
and Confocal Microscopy Analysis
Cells were washed with 16PBS, fixed for 10 minutes with 4%
paraformaldehyde-PBS, and then stained for CK18 and/or
CK14, as indicated. Confocal microscopy analysis was performed
using a Zeiss LAM 510Meta.
LacZ Staining in Whole Mammary Tissue
The bacterial beta-galactosidate gene lacZ is frequently used as
a reporter gene. The expression of transgenic constructs can be
monitored by histochemistry with the chromogenic substrate X-
gal. This allows precise cellular localization of gene activity. No
background staining was detectable in mammary tissue when lacZ
staining was performed. The mammary gland tissue was fixed for
2 hours in 2% paraformaldehyde, 0.25% glutaraldehyde, 0.01%
NP-40 in PBS. Slides were rinsed and incubated with PBS
containing 2 mM MgCl2, 0.01% Na-deoxycholate, and 0.02%
NP-40. The samples were incubated for 2 hours, followed by
addition of X-gal staining buffer containing 1 mg/ml X-gal. The
staining buffer contained: 30 mM K4Fe(CN)6,3 0 m M
K3Fe(CN)6.3H2O, 2 mM MgCl2, 0.01% Na-desoxycholate,
0.02% NP-40, 16PBS. The samples were then incubated at
30uC for 24 hours and analyzed under the microscope.
FISH Analysis
One mg of mouse Cot-1 DNA (Invitrogen, USA) was labeled
with SpectrumGreen-dUTP (Vysis Inc, USA), using nick transla-
tion kit (Abbott Molecular Inc., USA). Labeled Cot 1 DNA was
ethanol precipitated and reconstituted by hybridization buffer
(50% formamide, 2XSSC, 50 mM phosphate buffer, 10% dextran
sulfate). Mouse X and Y probes used in this study were
chromosome paints (X Cy3 labeled and Y FITC labeled) from
Cambio, UK. For paraffin tissue section, the slides were initially
incubated at 56uC overnight, then deparaffinized in Xylene,
dehydrated in 100% ethanol and air dried, followed by incubation
in TE at 100uC for 45 minutes. The slides were then treated with
150 ml of ZYMED Digest-All (Invitrogen, USA) under a plastic
coverslip at 37uC for 20 minutes, followed by rinsing in PBS and
dehydration in ethanol series. Two hundred ng of each probe
(total volume 8 ml) were placed onto the area under a 22622 mm
coverslip and sealed with rubber cement. The slides with probe
were denatured at 95uC for 3 minutes and hybridization was
performed in a moist chamber at 37uC for 48 hours. Hybridized
slides were washed in 0.56SSC at 72uC for 5 minutes, in 0.025%
Tween/PBS at RT for 2 minutes and dehydrated in ethanol series.
Finally, the slides were mounted with 12 ml of DAPI II (Abbott
Molecular Inc., USA). FISH slides were analyzed using an
Olympus microscope. Images were taken by using a CCD camera
and CytoVision software (Applied Imaging, Inc).
Statistical analysis
Statistical differences for the number of mammary outgrowths
in denuded mammary fat pads were determined using Student’s
t-test.
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